Mohammad Dastjerdi

Mohammad Dastjerdi practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Mohammad Dastjerdi's NPI, 1508200940, was assigned on April 27, 2013. Mohammad Dastjerdi graduated from Iran University of Medical Sciences in 1998. Mohammad Dastjerdi holds California license A137935.

Mohammad Dastjerdi's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Mohammad Dastjerdi's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Mohammad Dastjerdi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohammad Dastjerdi practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Mohammad Dastjerdi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Mohammad Dastjerdi is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Mohammad Dastjerdi's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists epilepsy, mobility impairment and seizures among the conditions Mohammad Dastjerdi treats.

CMS data shows 368 Medicare services from Mohammad Dastjerdi across 9 procedure codes in 2024, for 186 Medicare patients. Medicare paid $33,933 for them.

CMS counts 186 Medicare patients who saw Mohammad Dastjerdi in 2024. The largest group is under 65, with 88 patients. 70% of them have high blood pressure, and 62% have high cholesterol. 72% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohammad Dastjerdi's median patient age at 43, with 50% women.

In 2024, Mohammad Dastjerdi wrote 2,175 Medicare Part D claims for 200 patients. 86% of them were for generic drugs. CMS names the drug for 2,033 of them, across 36 drugs with 11 or more claims each, at $549,492 in total drug cost. In 2023, CMS named 1,832 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Mohammad Dastjerdi for performance year 2024, reported as part of a group. Mohammad Dastjerdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mohammad Dastjerdi as offering telehealth.

Dmand AI links 12 papers to Mohammad Dastjerdi, published from 2011 to 2025. 2011 was the busiest year, with 2. The most frequent topics are Electroencephalography, Brain Mapping and Mathematics. Mohammad Dastjerdi has published most often in J Neurosci. Mohammad Dastjerdi's most frequent co-authors are Josef Parvizi, MD, PhD, Mohammad Hossein Dastjerdi, MD and Andreas Maxmilim Rauschecker, MD, PhD.

CMS Open Payments shows 34 general payments to Mohammad Dastjerdi from 7 drug and device companies from 2018 to 2024. Travel and lodging make up the largest share, 62% of the total. Neuropace, Inc. paid the most, $4,047.

Mohammad Dastjerdi graduated from Iran University of Medical Sciences in 1998.

Mohammad Dastjerdi is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.